Back to Search

JASON ALTMAN, M.D.

Plastic Surgery Physician

NPI: 1164623955Individual

Specialties, Licenses & Credentials

Plastic Surgery PhysicianPrimary

Plastic Surgery

Code: 208200000X

ME101023(FL)

Research & Publications (20)

Nasal deformities associated with orthognathic surgery: analysis, prevention, and correction.
PMID 17667658·J Craniofac Surg·2007
6-review
Improvements in the lifestyle of patients who have had type 1 diabetes for 50 years: an optimistic message.
PMID 19034418·Diabetologia·2009
8-other
Prospects for mTOR targeting in adult T cell leukemia.
PMID 19373648·Leuk Lymphoma·2009
8-other
[Preventing childhood overweight by prenatal education of overweight or obese pregnant women].
PMID 19541087·Arch Pediatr·2009
8-other
Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia.
PMID 19652057·J Clin Oncol·2009
3-trial
Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness.
PMID 19129459·J Virol·2009
4-observational
Actual or ideal body weight to calculate CD34+ cell dose in patients undergoing autologous hematopoietic SCT for myeloma?
PMID 18836491·Bone Marrow Transplant·2009
8-other
The coagulopathy of acute promyelocytic leukaemia revisited.
PMID 19285282·Best Pract Res Clin Haematol·2009
6-review
IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.
PMID 19380868·Blood·2009
3-trial
Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
PMID 19542473·J Immunol·2009
7-preclinical
Optimizing the CD34 + cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation.
PMID 19603344·Leuk Lymphoma·2009
8-other
Activation of protein kinase C{eta} by type I interferons.
PMID 19211565·J Biol Chem·2009
7-preclinical
Exploiting the mammalian target of rapamycin pathway in hematologic malignancies.
PMID 18300753·Curr Opin Hematol·2008
6-review
Engaging families in child welfare services: worker versus client perspectives.
PMID 19189804·Child Welfare·2008
8-other
Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2.
PMID 18299328·J Biol Chem·2008
7-preclinical
Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part II: Panel performance across different instrument platforms.
PMID 18383309·Cytometry A·2008
4-observational
Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part I: Panel design by an empiric approach.
PMID 18383316·Cytometry A·2008
8-other
Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes.
PMID 18598196·J Infect Dis·2008
5-case
IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses.
PMID 18097036·J Immunol·2008
7-preclinical
Loss of IFN-gamma enables the expansion of autoreactive CD4+ T cells to induce experimental autoimmune encephalomyelitis by a nonencephalitogenic myelin variant antigen.
PMID 18354166·J Immunol·2008
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
550 BILTMORE WAY, SUITE 120
CORAL GABLES, FL 33134

Location

MARCELO M. GHERSI, M.D., P.A.

550 BILTMORE WAY, CORAL GABLES, FL
(305) 446-7700

Quick Facts

NPI
1164623955
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile